Golden Stapler Surgical Co., Ltd. (Golden Stapler),  a high-tech medical enterprise, focusing on minimally invasive anastomosis technology innovation, is pleased to announce that its Trocar, Endo Cutter and Reloads have successfully obtained certification from the Therapeutic Goods Administration (TGA) of Australia. This milestone not only marks the Golden Stapler’s products meeting the world’s strictest medical device standards but also officially opens the door to the Australian market, laying a solid foundation for its further global market expansion.

The certified Trocar and Endo Cutter and Reloads are core products of Golden Stapler’s minimally invasive surgical instrument series. Obtaining TGA certification is of great strategic significance for Golden Stapler. Australia, as an important market in the Asia-Pacific region with a strict medical regulatory system, it market recognition will further enhance the Golden Stapler’s brand influence and international competitiveness. Moreover, TGA certification is mutually recognized with many countries and regions including PIC/S member states, which will help the Golden Stapler reduce compliance costs in expanding into other international markets and accelerate its global layout.

Golden Stapler stated that it will take this certification as an opportunity to continue adhering to the concept of technological innovation and quality first, continuously optimize product performance, expand product lines, and provide more high-quality, safe, and reliable medical devices for global medical institutions and patients.

Moving forward, Golden Stapler will remain committed to its mission of “providing standardized anastomosis technology and professional minimally invasive surgical services for global clinical medicine”, continuously deepening technological research and development, improving quality management systems, and striving to become a leading enterprise in the global minimally invasive surgical instrument industry, making greater contributions to the development of global medical health cause.